AMD Flashcards

(29 cards)

1
Q

What are the modifiable risk factors for AMD?

A

Smoking
Weight
Lack of exercise
Hypertension
(Sunlight exposure)
(Heavy alcohol consumption)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the unmodifiable risk factors for AMD?

A

Age
Family history
(Caucasian race)
(Female gender)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What clinical features are present in early AMD?

A

Drusen
Pigmentary changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What clinical features are present in late AMD?

A

Geographic Atrophy
Choroidal Neovascularisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What clinical features are present in dry AMD?

A

Drusen
Pigmentary changes
Geographic Atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What clinical features are present in wet AMD?

A

Choroidal Neovascularisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are drusen and where do they form?

A

Lipid/protein extracellular deposits between Bruch’s membrane and the RPE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What size are drusen compared to to determine if they’re hard or soft?

A

63um (width of a blood vessel)
If under: hard AKA drupelets
If over: soft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is geographic atrophy?

A

Loss of PRs, revealing area of depigmentation so choroid is visible, well-circumscribed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is choroidal neovascularisation?

A

Neovasc originating from the choroid which breach Bruch’s membrane and invade sub-RPE/retina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What can CNV lead to?

A

Fibrovascular Proliferation (leads to vitreous haem and tractional retinal detachment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Fibrovascular Proliferation?

A

Growth of fibrous elements from new blood vessels which could contract, leading to vitreous haem and RD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What causes VEGF release?

A

Abnormal retinal changes seen in AMD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What happens as a result of VEGF release?

A

Neovascularisation, inflammation and increased vessel permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can AMD be imaged?

A

OCT
Fundus photography
Fluorescein angiography
Indocyanine green angiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is Fluorescein angiography helpful to assess AMD?

A

Can visualise CNV more easily as can view blood flow into choroid

17
Q

How is Indocyanine green angiography helpful in assessing AMD?

A

Visualises poorly circumscribed areas more easily due to longer wavelength of green dye (compared to NaFl)

18
Q

What are some previous treatments for AMD?

A

Surgical movement of macular
Photodynamic therapy

19
Q

How does anti-VEGF work?

A

The drug injected binds to receptor sites on VEGF, stopping it from binding - so stopping neovasc, inflammation and increased vessel permeability

20
Q

What is the brand name of Ranibizumab?
What is it licensed for?
What is injected?
How often is it injected?

Core

A

Lucentis
Wet AMD
Antibody fragment
Monthly injection

21
Q

What is the brand name of Bevacizumab?
What is it licensed for?
What is injected?
How often is it injected?

Further

A

Avastin
Oncology but used in AMD
Full length antibody
Monthly injection

22
Q

What is the brand name of Aflibercept?
What is injected?
How often is it injected?

Core

A

Eylea
‘VEGF trap’ fusion protein - decoy receptor
Injected every 8 weeks

23
Q

What is the brand name of Brolucizumab?
What is injected?

Further

A

Beovu
Single chain antibody fragment - small so penetrates and leaves circulation quickly

24
Q

What is the brand name of Faricimab?
What is injected?
How often is it injected?

Further

A

Vabysmo
Bispecific antibody - inhibits angoprotein-2 and VEGF
Injected every 16 weeks

25
What is the brand name of Pegaptanib? What is injected? When did NICE stop recommending its use?
Macugen RNA fragment 2015
26
What are the NICE guidelines for treatment of AMD?
VA - between 6/12 and 6/96 No permanent structural damage to central fovea lesions are less than or equal of 12 disc areas Evidence of recent disease progression (neovasc, VA changes, Amsler distortion)
27
What are possible future treatments?
Gene therapy Anti-inflammatory therapy (corticosteroids) Combination of anti-VEGF and corticosteroids Stem cell therapies
28
What nutritional guidance should you give to patients with AMD?
Eat lots of dark green leafy veg and orange/yellow foods Fish 3-4 times per week Supplements of vitamins/minerals (not specific brands!)
29
What nutrients help to defend against oxidative damage in the retina?
Vitamins C and E Beta-carotene Zinc Omega-3 fatty acids Carotenoids (Lutein and Zeaxanthin)